Sign in to view content

Two-Year Results of an Ongoing Phase 1b/2 Open-Label Clinical Trial of AU-011 for the Primary Treatment of Small to Medium Choroidal Melanoma

Amy C. Schefler, MD FACS FASRS

Video
Published 2019

Amy C. Schefler, MD

Ocular Oncology Symposium

Related

Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD
Peter A. Campochiaro, MD
Updates from the Field
2020
Episode 188: September 2019 Retinal Physician, Diabetic Retinopathy with Dr. Shriji Patel and Dr. Basil Williams
Jayanth Sridhar, MD
Member Podcasts
OCT and Autofluorescence of Peripapillary Versus Macular Variants of Combined Hamartoma of the Retina and Retinal Pigment Epithelium
J. Fernando Arevalo, MD, PhD, FACS, FASRS
Annual Meeting Talks
2019

Category: Ocular Oncology

See more